AccuVein AV400 for vein visualisation (MIB6)Product type:AdviceProgramme:Medtech innovation briefingPublished: 23 June 2014
Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use (NG15)Product type:GuidanceProgramme:NICE guidelinePublished: 18 August 2015
Community pharmacies: promoting health and wellbeing (NG102)Product type:GuidanceProgramme:NICE guidelinePublished: 2 August 2018
Community pharmacies: promoting health and wellbeing (QS196)Product type:Quality standardPublished: 28 August 2020
Controlled drugs: safe use and management (NG46)Product type:GuidanceProgramme:NICE guidelinePublished: 12 April 2016
Developing and updating local formularies (MPG1)Product type:GuidanceProgramme:Medicines practice guidelineLast updated: 28 October 2015Published: 14 March 2014
Diabetes (type 1 and type 2) in children and young people: diagnosis and management (NG18)Product type:GuidanceProgramme:NICE guidelineLast updated: 11 May 2023Published: 1 August 2015
Intravenous fluid therapy in adults in hospital (CG174)Product type:GuidanceProgramme:Clinical guidelineLast updated: 5 May 2017Published: 10 December 2013
Intravenous fluid therapy in adults in hospital (QS66)Product type:Quality standardPublished: 14 August 2014
Intravenous fluid therapy in children and young people in hospital (NG29)Product type:GuidanceProgramme:NICE guidelineLast updated: 11 June 2020Published: 9 December 2015
Intravenous fluid therapy in children and young people in hospital (QS131)Product type:Quality standardPublished: 21 September 2016
Managing medicines for adults receiving social care in the community (NG67)Product type:GuidanceProgramme:NICE guidelinePublished: 30 March 2017
Managing medicines in care homes (SC1)Product type:GuidanceProgramme:Social care guidelinePublished: 14 March 2014
Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence (CG76)Product type:GuidanceProgramme:Clinical guidelinePublished: 28 January 2009
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults (NG215)Product type:GuidanceProgramme:NICE guidelinePublished: 20 April 2022
Medicines management for people receiving social care in the community (QS171)Product type:Quality standardPublished: 24 July 2018
Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes (NG5)Product type:GuidanceProgramme:NICE guidelinePublished: 4 March 2015
Patient group directions (MPG2)Product type:GuidanceProgramme:Medicines practice guidelineLast updated: 27 March 2017Published: 2 August 2013
Physical health of people in prison (NG57)Product type:GuidanceProgramme:NICE guidelinePublished: 2 November 2016
Reversal of the anticoagulant effect of dabigatran: idarucizumab (ESNM73)Product type:AdviceProgramme:Evidence summaryPublished: 24 May 2016
Safe prescribing and withdrawal management of prescribed drugs associated with dependence and withdrawalStatus:Awaiting developmentExpected publication date: TBC
Type 2 diabetes in adults: management (medicines update)Status:In developmentProgramme:NICE guidelineExpected publication date: 19 June 2025
YOURmeds for medication support in long-term conditions (MIB289)Product type:AdviceProgramme:Medtech innovation briefingLast updated: 9 June 2023Published: 15 March 2022